These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1906 related articles for article (PubMed ID: 15609292)

  • 1. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effective treatment with rituximab in a patient with refractory idiopathic thrombocytopenic purpura].
    Tanai C; Iki S; Nakahara F; Iijima K; Usuki K; Kuwana M; Urabe A
    Rinsho Ketsueki; 2004 Nov; 45(11):1181-6. PubMed ID: 15609684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranous nephropathy and thrombotic thrombocytopenic purpura treated with rituximab.
    Kuppachi S; Chander P; Yoo J
    J Nephrol; 2009; 22(4):561-4. PubMed ID: 19662613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C
    Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
    Riksen NP; Keuning JJ; Vreugdenhil G
    Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
    Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
    Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab].
    Kawachi Y; Ide M; Uchida T; Setsu K
    Rinsho Ketsueki; 2003 Jan; 44(1):31-3. PubMed ID: 12649836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M; Iki S; Urabe A
    Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
    Patino W; Sarode R
    J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
    Cooper N; Stasi R; Cunningham-Rundles S; Feuerstein MA; Leonard JP; Amadori S; Bussel JB
    Br J Haematol; 2004 Apr; 125(2):232-9. PubMed ID: 15059147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
    Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
    Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
    Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME
    Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
    Latifzadeh SZ; Entezari V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
    Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
    Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
    Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
    Saleh MN; Gutheil J; Moore M; Bunch PW; Butler J; Kunkel L; Grillo-López AJ; LoBuglio AF
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):99-103. PubMed ID: 11226008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 96.